Report error Found 64 Enz. Inhib. hit(s) with all data for entry = 7589
Affinity DataKi: 1.20nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 2.66nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 2.75nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 3.46nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 3.5nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 4.11nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 4.47nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 6nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 6.40nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 7.26nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 8.06nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 10.3nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 11nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 12.8nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 19.2nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 31.8nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 33.5nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 35nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 51nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 60.4nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 73nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 73.6nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 74.8nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 82.4nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 87nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 90nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 91.5nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 95.7nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 96.7nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 104nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 106nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 110nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 128nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 133nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 137nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 150nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 151nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 170nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 172nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 175nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 199nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 203nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 207nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 267nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 304nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 327nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 328nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 376nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 456nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
Affinity DataKi: 460nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
